Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function

Einat Shomer, Sarah Katzenell, Yaniv Zipori, Annie Rebibo-Sabbah, Benjamin Brenner, Anat Aharon*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Introduction Microvesicles including exosomes and microparticles, participate in the placental-maternal crosstalk in normal pregnancies and gestational vascular complications (GVC). Low molecular weight heparin (LMWH) is known to reduce the risk of placenta-mediated pregnancy complications. This study was aimed to characterize microvesicles of pregnant women receiving LMWH and explore microvesicle involvement in trophoblast and endothelial cell function. Materials and methods Microvesicles were isolated from blood samples obtained from non-pregnant women, healthy pregnant women (HP) and pregnant woman treated with LMWH. Microvesicle protein contents were assessed by protein array and ELISA. Microvesicle effects on early stage trophoblasts, term trophoblasts and endothelial cell migration, angiogenesis and apoptosis were evaluated. Results Microvesicles derived from the group treated with LMWH contained higher levels of several proangiogenic proteins compared to those of HP women. Exposure of endothelial cells to circulating microvesicles derived from HP and LMWH treated groups induced significantly higher cell migration and branch tube formation compared to untreated cells. The effect of microvesicles from HP- and LMWH groups on early-stage trophoblast migration was similar. Microvesicles derived from these two study groups significantly decreased early-stage trophoblast apoptosis, while microvesicles derived from the HP-group (but not from the LMWH-group) significantly increased the term trophoblast apoptosis (TUNEL assay) compared to untreated cells. Conclusion Therapy with LMWH affects patients' microvesicle content, leading to normalization of invasion, angiogenesis activity and survival of endothelial and trophoblast cells in vitro. The effects of LMWH on microvesicles may point to an additional mechanism of heparin action in high-risk pregnancy.

Original languageEnglish
Pages (from-to)141-147
Number of pages7
JournalThrombosis Research
StatePublished - 1 Jan 2016
Externally publishedYes


FundersFunder number
German-Israel Foundation156-202-14/2006
Rappaport Institute046-01


    • Apoptosis
    • Endothelial cells
    • Low molecular weight heparin (LMWH)
    • Microvesicles (MVs)
    • Pregnancy
    • Trophoblasts


    Dive into the research topics of 'Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function'. Together they form a unique fingerprint.

    Cite this